AI CAPITAL INTELLIGENCE
Artis Ventures | Institution profile
Institution at a glance
ARTIS, listed in this database as Artis Ventures, is a San Francisco venture firm whose website frames its mission around using frontier technologies to improve human health and resilience, including through AI. Its public team includes Founder and Managing Partner Stuart Peterson, Senior Partner Austin Walne and Senior Partner Ruchita Sinha.
Source verification date: · The official brand is ARTIS; the funding database name is Artis Ventures. Investment, board and exit examples are drawn from individual team biographies and are not presented as fund-level performance. The Valarian source supports ARTIS’s role in a May 2025 USD 7 million seed round only; it does not establish participation in Valarian’s July 2026 USD 50 million Series A.
Names follow their disclosed form. Descriptive English renderings of Chinese names are not verified legal names. Original quotations are shown in their source language.
Key facts
| Official brand | ARTIS; the financing database records the entity as Artis Ventures. |
|---|---|
| Investment mission | Frontier technologies aimed at making the human condition more resilient, with official materials highlighting AI, health and life sciences. |
| Leadership biographies | Stuart Peterson — Founder and Managing Partner; his official biography lists investments and board work across healthcare, biotechnology and software.、Austin Walne — Senior Partner; focuses on technology and biology convergence, with prior work in private-company secondary-market advisory, software development and product management.、Ruchita Sinha — Senior Partner; invests at the intersection of biology, healthcare, data and AI; her biography lists AV8 Ventures, Sanofi Ventures, GE Ventures, Maxygen, Pfizer and L.E.K. Consulting. |
| San Francisco office | 499 Jackson Street, Suite 400, San Francisco, CA 94111, USA. |
Organization background
ARTIS’s website lists Stuart Peterson’s investment and board history, including YouTube (acquired by Google), StemCentrx (acquired by AbbVie) and Palantir (IPO). Ruchita Sinha’s biography says she has backed 30+ life-science and healthcare companies, with about a dozen exits and multiple unicorns. These are individual career records, not fund-level returns.
Public record
- Team-history examples: Stuart Peterson’s biography lists YouTube, StemCentrx and Palantir among investments and board work, with the stated acquisition or IPO outcomes. This is an individual track record, not fund-level performance.
- Ruchita Sinha’s official biography reports experience with 30+ life-science and healthcare companies, about a dozen exits and multiple unicorns; this is an individual career metric.
- Historical financing evidence: a 2026 Tech Funding News article says Artis Ventures co-led Valarian Technologies’ previous USD 7 million seed round, which closed in May 2025. The source does not establish ARTIS participation in the USD 50 million Series A disclosed on 2026-07-14.
Official contact details
- Official website: ARTIS
- San Francisco office: 499 Jackson Street, Suite 400, San Francisco, CA 94111, USA
Sources
- 1. ARTIS — Mission and company overview
ARTIS is guided by a singular belief: that the future of the human condition can be made more resilient through the bold application of frontier technologies.
- 2. ARTIS — Our team
Stuart Peterson is the Founder and Managing Partner of ARTIS.
- 3. Valarian raises $50M; its previous $7M seed was co-led by Artis Ventures — Tech Funding News
Its previous round — a $7 million seed co-led by Artis Ventures, an early Palantir backer, and Scout Ventures — closed in May 2025.